The effects of implementing virtual reality headsets during transarterial treatment of malignant liver tumors

Recruiting

• Conditions: C22.0; Liver cell carcinoma

• Registration Number: DRKS00030195
• Lead Sponsor: niversitätsklinikum Freiburg im Breisgau

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-02-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

clinically indicated transarterial chemoembolization of the liver
- signed study consent form

Exclusion Criteria

- Contraindication for clinically indicated transarterial chemoembolization
chemoembolization
-Patient age under 18 years
- Migraine with aura
- claustrophobia
- Epilepsy
- Severe balance disorder
- Kinetosis
- Acute psychosis

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. State-Trait Anxiety Inventory - Trait Version (STAI- T) and State Version <br>(STAI-S)

Secondary Outcome Measures

Name	Time	Method
2. Likert scale to assess the sensation of pain <br>3. diagnosis of the occurrence of postembolic syndrome during the hospital stay <br>4. vital signs<br>5. simulator sickness questionnaire (not in the control group without VR headset) <br>6. ingroup presence questionnaire (not in the control group without VR headset) <br>7. examination time, fluoroscopy time, radiation dose <br>8. survey of the physicians performing the treatment with regard to patient <br>communication during the procedure